Health Care Up As BioNTech Rallies -- Health Care Roundup

10/21/2021 | 05:18pm

Health-care companies ticked up amid optimism about vaccine sales.

A third dose of the Covid-19 vaccine from Pfizer and BioNTech SE was found in a large study to be highly protective against symptomatic Covid-19, the companies said. Shares of BioNTech surged after the report.

Bluebird Bio continued its retreat from the European Union, where it said it could not receive what it considered a fair price for its gene therapy, pulling an approval application for a therapy targeting a rare neuromuscular disease.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

10-21-21 1717ET

Copier lien
Latest news about "Economy & Forex"
4h ago
4h ago
4h ago
4h ago
5h ago